___________________________________________________________________________ Colorectal Cancer 310. Peeters M, Price TJ, Cervantes A, et al. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer. J Clin Oncol . 2010;28(31):4706-4713. 311. Grothey A, Van Cutsem E, Sobrero A, et al. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet . 2013;381(9863):303-312. 312. Cunningham D, Pyrhönen S, James RD, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet . 1998;352(9138):1413-1418. 313. Khan AN. Liver Metastases Imaging. Available at https://emedicine.medscape.com/article/369936-overview#a1. Last accessed March 7, 2022. 314. Masi G, Vasile E, Loupakis F, et al. Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis. J Natl Cancer Inst . 2011;103(1):21-30. 315. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg . 1990;77(11):1241-1246. 316. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet . 1994;343(8910):1405-1410. 317. Gallinger S, Biagi JJ, Fletcher GG, et al. Liver Resection for Colorectal Metastases: Evidence-Based Series No. 17-7. Available at https://www.cancercareontario.ca/en/guidelines-advice/types-of-cancer/2236. Last accessed March 7, 2022. 318. Shah SA, Bromberg R, Coates A, et al. Survival after liver resection for metastatic colorectal carcinoma in a large population. J Am Coll Surg . 2007;205(5):676-683. 319. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg . 2004;239(6):818-827. 320. Quan D, Gallinger S, Nhan C, et al. The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: a systematic review. Surgery . 2012;151(6):860-870. 321. Shah SA, Haddad R, Al-Sukhni W, et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg . 2006;202(3):468-475. 322. Portier G, Elias D, Bouche O, et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol . 2006;24(31):4976-4982. 323. Mitry E, Fields AL, Bleiberg H, et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol . 2008;26(30):4906-4911. 324. Ychou M, Hohenberger W, Thezenas S, et al. A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Ann Oncol . 2009;20(12):1964-1970. 325. Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet . 2008;371(9617):1007-1016. 326. Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med . 1999;341(27):2039-2048. 327. Mocellin S, Pilati P, Lise M, Nitti D. Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? J Clin Oncol . 2007;25(35):5649-5654. 328. Pawlik TM, Izzo F, Cohen DS, Morris JS, Curley SA. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol . 2003;10(9):1059-1069. 329. National Institute for Health and Care Excellence. Radiofrequency Ablation for Colorectal Liver Metastases. Available at https://www. nice.org.uk/guidance/ipg327. Last accessed March 7, 2022. 330. Ravikumar TS, Kaleya R, Kishinevsky A. Surgical ablative therapy of liver tumors. PPO Updates . 2000;14:1-12. 331. Bageacu S, Kaczmarek D, Lacroix M, Dubois J, Forest J, Porcheron J. Cryosurgery for resectable and unresectable hepatic metastases from colorectal cancer. Eur J Surg Oncol . 2007;33(5):590-596. 332. Ravikumar TS. Interstitial therapies for liver tumors. Surg Oncol Clin N Am . 1996;5(2):365-377. 333. Headrick JR, Miller DL, Nagorney DM, et al. Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg . 2001;71(3):975-979. 334. Dowswell G, Ismail T, Greenfield S, Clifford S, Hancock B, Wilson S. Men’s experience of erectile dysfunction after treatment for colorectal cancer: qualitative interview study. BMJ . 2011;343:d5824. 335. Meyerhardt JA, Mangu PB, Flynn PJ, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol . 2013;31(35):4465- 4470. 336. Pfister DG, Benson AB 3rd, Somerfield MR. Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. N Engl J Med . 2004;350(23):2375-2382.
Powered by FlippingBook